Analgesic effect of different doses of granisetron with lidocaine for intravenous regional anesthesia
Phase 3
- Conditions
- Regional anesthesia.Local anaesthetics
- Registration Number
- IRCT2014091214056N4
- Lead Sponsor
- Arak University of Medical Sciences, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
age between 20 to 50 years old; ASA I or II.
Exclusion criteria: history of drug allergy; pregnancy; contraindication of intravenous regional anesthesia like sickle cell anemia; use of opiate and analgesic drugs; use of Apomorphine.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tourniquet pain. Timepoint: 0, 15, 30 and 45 minute after injection. Method of measurement: VAS.
- Secondary Outcome Measures
Name Time Method Reduction of pain. Timepoint: Every 30 minutes until 2 hours after removing tourniquet. Method of measurement: VAS.;Vital signs. Timepoint: After removing tourniquet. Method of measurement: Physical examination.;O2 saturation. Timepoint: After removing tourniquet. Method of measurement: Pulse oxymeter.;Need to Fentanyl. Timepoint: 0, 15, 30 and 45 min after injection. Method of measurement: Drug dose that is used.